Cargando…
Prevalence, incidence and clinical outcomes of epicardial coronary artery disease among transthyretin amyloidosis cardiomyopathy patients
BACKGROUND: Transthyretin amyloidosis cardiomyopathy (ATTR-CM) patients are often older and may be at risk for obstructive epicardial coronary artery disease (oeCAD). While ATTR-CM may cause small vessel coronary disease, the prevalence and clinical significance of oeCAD is not well described. METHO...
Autores principales: | Hassan, Rana, Miller, Robert J. H., Howlett, Jonathan G., White, James A., Fine, Nowell M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9996970/ https://www.ncbi.nlm.nih.gov/pubmed/36890444 http://dx.doi.org/10.1186/s12872-023-03140-y |
Ejemplares similares
-
Assessment and Management of Older Patients With Transthyretin Amyloidosis Cardiomyopathy: Geriatric Cardiology, Frailty Assessment and Beyond
por: Irabor, Biobelemoye, et al.
Publicado: (2022) -
Disease-Modifying Therapy for Transthyretin Amyloidosis: Where to Start? Where to Stop?
por: Fine, Nowell M.
Publicado: (2020) -
Hereditary transthyretin amyloidosis: a case report
por: Lee, Angela, et al.
Publicado: (2022) -
Frequency of hereditary transthyretin amyloidosis among elderly patients with transthyretin cardiomyopathy
por: Maestro‐Benedicto, Alba, et al.
Publicado: (2022) -
Diagnosis and treatment of transthyretin‐related amyloidosis cardiomyopathy
por: Teng, Catherine, et al.
Publicado: (2020)